|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVITED REVIEWS
Department of Integrative Physiology, University of Colorado at Boulder, Boulder, Colorado
Submitted 4 May 2006 ; accepted in final form 1 August 2006
Cardiolipin (CL) is a structurally unique dimeric phospholipid localized in the inner mitochondrial membrane where it is required for optimal mitochondrial function. In addition to its role in maintaining membrane potential and architecture, CL is known to provide essential structural and functional support to several proteins involved in mitochondrial bioenergetics. A loss of CL content, alterations in its acyl chain composition, and/or CL peroxidation have been associated with mitochondrial dysfunction in multiple tissues in a variety of pathological conditions, including ischemia, hypothyroidism, aging, and heart failure. Recently, aberrations in CL metabolism have been implicated as a primary causative factor in the cardioskeletal myopathy known as Barth syndrome, underscoring an important role of CL in human health and disease. The purpose of this review is to provide an overview of evidence that has linked changes in the CL profile to mitochondrial dysfunction in various pathological conditions. In addition, a brief overview of CL function and biosynthesis, and a discussion of methods used to examine CL in biological tissues are provided.
phospholipid; metabolism; heart failure; aging; hypothyroidism; lipid peroxidation; oxidative stress; diet; ischemia
This article has been cited by other articles:
![]() |
C. Osman, C. Merkwirth, and T. Langer Prohibitins and the functional compartmentalization of mitochondrial membranes J. Cell Sci., November 1, 2009; 122(21): 3823 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Taylor and G. M. Hatch Identification of the Human Mitochondrial Linoleoyl-coenzyme A Monolysocardiolipin Acyltransferase (MLCL AT-1) J. Biol. Chem., October 30, 2009; 284(44): 30360 - 30371. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Petrosillo, G. Colantuono, N. Moro, F. M. Ruggiero, E. Tiravanti, N. Di Venosa, T. Fiore, and G. Paradies Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1487 - H1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Shah, M. K. Duda, K. M. O'Shea, G. C. Sparagna, D. J. Chess, R. J. Khairallah, I. Robillard-Frayne, W. Xu, R. C. Murphy, C. Des Rosiers, et al. The Cardioprotective Effects of Fish Oil During Pressure Overload Are Blocked by High Fat Intake: Role Of Cardiac Phospholipid Remodeling Hypertension, September 1, 2009; 54(3): 605 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Heather, C. A. Carr, D. J. Stuckey, S. Pope, K. J. Morten, E. E. Carter, L. M. Edwards, and K. Clarke Critical role of complex III in the early metabolic changes following myocardial infarction Cardiovasc Res, August 31, 2009; (2009) cvp276v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Saini-Chohan, M. G. Holmes, A. J. Chicco, W. A. Taylor, R. L. Moore, S. A. McCune, D. L. Hickson-Bick, G. M. Hatch, and G. C. Sparagna Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure J. Lipid Res., August 1, 2009; 50(8): 1600 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Robinson, K. L. Hamilton, and B. F. Miller The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise J Appl Physiol, July 1, 2009; 107(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kiebish, X. Han, H. Cheng, J. H. Chuang, and T. N. Seyfried Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer J. Lipid Res., December 1, 2008; 49(12): 2545 - 2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nguyen, M. Ogbi, and J. A. Johnson Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester: IMPLICATIONS FOR F1F0 ATPase REGULATION J. Biol. Chem., October 31, 2008; 283(44): 29831 - 29840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Claypool, Y. Oktay, P. Boontheung, J. A. Loo, and C. M. Koehler Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane J. Cell Biol., September 9, 2008; 182(5): 937 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chicco, G. C. Sparagna, S. A. McCune, C. A. Johnson, R. C. Murphy, D. A. Bolden, M. L. Rees, R. T. Gardner, and R. L. Moore Linoleate-Rich High-Fat Diet Decreases Mortality in Hypertensive Heart Failure Rats Compared With Lard and Low-Fat Diets Hypertension, September 1, 2008; 52(3): 549 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada Mitochondrial Import and Accumulation of {alpha}-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain J. Biol. Chem., April 4, 2008; 283(14): 9089 - 9100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chicco, S. A. McCune, C. A. Emter, G. C. Sparagna, M. L. Rees, D. A. Bolden, K. D. Marshall, R. C. Murphy, and R. L. Moore Low-Intensity Exercise Training Delays Heart Failure and Improves Survival in Female Hypertensive Heart Failure Rats Hypertension, April 1, 2008; 51(4): 1096 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kulik, H. van Lenthe, F. S. Stet, R. H. Houtkooper, H. Kemp, J. E. Stone, C. G. Steward, R. J. Wanders, and F. M. Vaz Bloodspot Assay Using HPLC-Tandem Mass Spectrometry for Detection of Barth Syndrome Clin. Chem., February 1, 2008; 54(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jahangir, S. Sagar, and A. Terzic Aging and cardioprotection J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sparagna, A. J. Chicco, R. C. Murphy, M. R. Bristow, C. A. Johnson, M. L. Rees, M. L. Maxey, S. A. McCune, and R. L. Moore Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure J. Lipid Res., July 1, 2007; 48(7): 1559 - 1570. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |